ELIZABETH GREENWOOD: Open Payments
NPI 1619381753 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 40 payments from 15 companies in 2025. Trend: 2023 $167 · 2024 $854 · 2025 $960
Food & beverage: $876Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $177 |
| Boston Scientific Corporation | 1 | $133 |
| Janssen Biotech, Inc. | 2 | $112 |
| Phathom Pharmaceuticals, Inc. | 6 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Ardelyx, Inc. | 3 | $51 |
| PFIZER INC. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| GENZYME CORPORATION | 2 | $39 |
Products named: General - Pain Management, TREMFYA, RINVOQ, VOQUEZNA, ENTYVIO, ZENPEP, IBSRELA, CREON.
Industry payments across NC — which companies pay providers there.
